Adagene Reports Full Year 2022 Financial Results and Provides Corporate Update
28. März 2023 16:30 ET
|
Adagene Inc.
- Clinical data for wholly-owned anti-CTLA-4 franchise show best-in-class safety profiles for unmasked and masked candidates, unlocking the full therapeutic benefit of anti-CTLA-4 in combination with...